Joana Cardia1, Cármen Calçada1, Helena Pereira1. 1. Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE (Portuguese Institute of Oncology - Porto), Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Abstract
BACKGROUND: More than 50% of new cases of lung cancer (LC) are diagnosed in elderly patients. It is necessary to know correct treatment of these patients but there is a lack of evidence-based data regarding this age group, leading to an undertreatment based on a supposed lack of tolerance to radical treatments. AIM: To evaluate the results of radiotherapy (RT) treatment in elderly patients with LC in our institution and the relation between survival, toxicity and comorbidities. MATERIALS AND METHODS: We retrospectively analyzed all patients over 70 years old with LC, treated with RT with or without chemotherapy (CT), in the radiotherapy department of the Instituto Português de Oncologia do Porto Francisco Gentil (IPOPFG), between January 2000 and December 2007. RESULTS: Three-year overall survival (OS) rate was 33.8%. Median progression free survival was 18.1 months. For patients treated with exclusive radical radiotherapy the 3-year OS rate was 51.5% and for patients treated with sequential and concurrent CTRT, 3-year survival rates were 44% and 25.4%, respectively. We did not find a statistical relationship between the presence of comorbidities and survival. Toxicity presented by the patients was not influenced by comorbidities and did not influence survival. CONCLUSION: Our results allow us to conclude that elderly patients are likely to benefit from radical treatments. Chemo-radiotherapy seems to increase survival but should be used carefully in old patients outside clinical trials. Comorbidities did not seem to influence survival and toxicity of treatments, although larger studies are necessary to prove this.
BACKGROUND: More than 50% of new cases of lung cancer (LC) are diagnosed in elderly patients. It is necessary to know correct treatment of these patients but there is a lack of evidence-based data regarding this age group, leading to an undertreatment based on a supposed lack of tolerance to radical treatments. AIM: To evaluate the results of radiotherapy (RT) treatment in elderly patients with LC in our institution and the relation between survival, toxicity and comorbidities. MATERIALS AND METHODS: We retrospectively analyzed all patients over 70 years old with LC, treated with RT with or without chemotherapy (CT), in the radiotherapy department of the Instituto Português de Oncologia do Porto Francisco Gentil (IPOPFG), between January 2000 and December 2007. RESULTS: Three-year overall survival (OS) rate was 33.8%. Median progression free survival was 18.1 months. For patients treated with exclusive radical radiotherapy the 3-year OS rate was 51.5% and for patients treated with sequential and concurrent CTRT, 3-year survival rates were 44% and 25.4%, respectively. We did not find a statistical relationship between the presence of comorbidities and survival. Toxicity presented by the patients was not influenced by comorbidities and did not influence survival. CONCLUSION: Our results allow us to conclude that elderly patients are likely to benefit from radical treatments. Chemo-radiotherapy seems to increase survival but should be used carefully in old patients outside clinical trials. Comorbidities did not seem to influence survival and toxicity of treatments, although larger studies are necessary to prove this.
Authors: Steven E Schild; Philip J Stella; Susan M Geyer; James A Bonner; William L McGinnis; James A Mailliard; Jeffery Brindle; Aminah Jatoi; James R Jett Journal: J Clin Oncol Date: 2003-07-21 Impact factor: 44.544
Authors: Steven E Schild; Sumithra J Mandrekar; Aminah Jatoi; William L McGinnis; Phillip J Stella; Richard L Deming; James R Jett; Yolanda I Garces; Katie L Allen; Alex A Adjei Journal: Cancer Date: 2007-07-15 Impact factor: 6.860
Authors: Andrzej Lebioda; Roman Makarewicz; Bogdan Małkowski; Maciej Dancewicz; Janusz Kowalewski; Wieslawa Windorbska Journal: Rep Pract Oncol Radiother Date: 2013-01-05
Authors: Ladislav Slovacek; Jindřich Kopecký; Peter Priester; Birgita Slováčková; Iva Slánská; Jiří Petera Journal: Rep Pract Oncol Radiother Date: 2012-08-30
Authors: Jon Cacicedo; Francisco Casquero; Lorea Martinez-Indart; Olga Del Hoyo; Alfonso Gómez de Iturriaga; Irma Muruzabal; Claudia Carvajal; Elsira Bóveda; Blanca Ruiz; Armando Loayza; Begoña Usategui; Aurora Lasso; Eduardo Hortelano; Pedro Bilbao Journal: Rep Pract Oncol Radiother Date: 2012-08-24
Authors: Jon Cacicedo; Francisco Casquero; Lorea Martinez-Indart; Olga del Hoyo; Alfonso Gomez de Iturriaga; Arturo Navarro; Pedro Bilbao Journal: Chin J Cancer Date: 2013-10-09